Dr. Alok Kanojia (Dr. K)

speaker
1,658 appearances 5 recordings 3 series first heard Sep 2025 last heard 27 May

Dr. Alok Kanojia (Dr. K)’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months
2 · Oct OctJan 26AprJulnow

Recordings per month over the last 12 months — 4 in all, peaking in Oct 2025 with 2.

Appearances

newest first · ▶ plays the moment
Next thing we're going to talk about is microdosing.
So microdosing is like all the fad nowadays.
I've met a ton of people who really love to microdose.
So microdosing is when you take, you know, a small dose of psychedelics.
And this also is where, like, we have to get technical because what is the dose of microdosing, right?
So there's no clear consensus.
So if we're asking, is microdosing effective?
Is it safe?
The question becomes, which psychedelic are we talking about?
And at what dose are we talking about?
I don't hear this level of precision.
So we can't say it is safe or unsafe or effective or ineffective unless we actually specify those things, okay?
That's the first problem.
So second thing is that in my experience of microdosing, in the sense of the people that I've worked with, what I tend to find is that microdosing gives a lot of subjective benefit.
So when people microdose, they feel a lot better.
They feel like it has a very large impact.
But that is generally speaking, I think, kind of sus, TBH.
And the reason for that is because a subjective experience of feeling better does not necessarily tightly correlate with an actual clinical improvement.
And the best example of this is something like Adderall or stimulant medication.
So if you take someone with ADHD and you give them Adderall, what many of them experience is that they are non-functional without Adderall.
Showing 541–560 of 1,658 · page 28 of 83 ← Previous Next →